Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All HCQ studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19hcq.org COVID-19 treatment researchHCQHCQ (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Mortality risk factors in patients with SARS-CoV-2 infection and atrial fibrillation: Data from the SEMI-COVID-19 registry

Azaña Gómez et al., Medicina Clínica, doi:10.1016/j.medcli.2022.01.008
Mar 2022  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality 36% Improvement Relative Risk HCQ for COVID-19  Azaña Gómez et al.  LATE TREATMENT Is late treatment with HCQ beneficial for COVID-19? Retrospective 1,799 patients in Spain (March - October 2020) Lower mortality with HCQ (p<0.000001) c19hcq.org Azaña Gómez et al., Medicina Clínica, Mar 2022 FavorsHCQ Favorscontrol 0 0.5 1 1.5 2+
HCQ for COVID-19
1st treatment shown to reduce risk in March 2020
 
*, now with p < 0.00000000001 from 411 studies, recognized in 46 countries.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,300+ studies for 75 treatments. c19hcq.org
Retrospective 1,816 COVID-19 patients with atrial fibrillation in Spain, showing lower mortality with HCQ treatment.
This study is excluded in the after exclusion results of meta analysis: unadjusted results with no group details.
risk of death, 35.8% lower, RR 0.64, p < 0.001, treatment 500 of 1,378 (36.3%), control 238 of 421 (56.5%), NNT 4.9.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Azaña Gómez et al., 10 Mar 2022, retrospective, Spain, peer-reviewed, 10 authors, study period 1 March, 2020 - 1 October, 2020.
This PaperHCQAll
Factores de riesgo de mortalidad en pacientes con infección por SARS-CoV-2 y fibrilación auricular: datos del registro SEMI-COVID-19
Javier Azaña Gómez, Luis M Pérez-Belmonte, Manuel Rubio-Rivas, José Bascuñana, Raúl Quirós-López, María Luisa Taboada Martínez, Esther Montero Hernandez, Fernando Roque-Rojas, Manuel Méndez-Bailón, Ricardo Gómez-Huelgas
Medicina Clínica, doi:10.1016/j.medcli.2022.01.008
Introducción: La fibrilación auricular y las comorbilidades asociadas a ella suponen un factor de riesgo de mortalidad, morbilidad y de desarrollo de complicaciones en los pacientes ingresados por COVID-19. Objetivos: Describir las características clínicas, epidemiológicas, radiológicas y analíticas de los pacientes con fibrilación auricular ingresados por COVID-19 en Espa ña. De forma secundaria, se pretende identificar aquellas variables que se asocian con mortalidad y mal pronóstico de la COVID-19 en pacientes que presentan fibrilación auricular. Métodos: Estudio retrospectivo, observacional y multicéntrico de ámbito nacional de pacientes hospitalizados por COVID-19 desde el 1 de marzo hasta el 1 de octubre de 2020. Los datos fueron obtenidos del Registro SEMI-COVID-19 de la Sociedad Espa ñola de Medicina Interna (SEMI) en el que participan 150 hospitales espa ñoles. Resultados: De un total de 16.461 pacientes en el registro SEMI-COVID-19, 1.816 (11%) tenían antecedente de fibrilación auricular y el número de fallecidos entre los pacientes con fibrilación auricular ascendió a 738 (41%). En cuanto a la clínica, los pacientes fallecidos ingresaron con una frecuencia cardíaca mayor (88,38 vs. 84,95; p > 0,01), con mayor porcentaje de insuficiencia respiratoria (67,2 vs. 20,1%; p < 0,01) y mayor taquipnea (58 vs. 30%; p< 0,09). En el análisis multivariante, el tratamiento con ACOD tuvo un papel protector para la mortalidad por infección por COVID-19 (OR: 0,597; IC: 0,402-0,888; p = 0,011). Conclusiones: Tanto el tratamiento previo con ACOD como el tratamiento con ACOD durante el ingreso parecen tener un papel protector en los pacientes con fibrilación auricular, aunque este hecho debería ser comprobado con estudios prospectivos.
References
Al-Abbas, Alshaikhli, Amran, New-onset atrial fibrillation and multiple systemic emboli in a COVID-19 patient, Cureus
Alonso Gisbert, Blázquez Llistosella, Casanova, García Flores, Hinojo et al., Hospital do Salnes (Villagarcía de Arosa
Anexo, Listado de los investigadores del Registro SEMI-COVID-19 Coordinador del Registro SEMI-COVID-19: José Manuel Casas Rojo
Aparicio, Bernabeu-Wittel, Suárez, Nieto, Miranda et al., Hospital Público de Monforte de Lemos
Aranega González, Boixeda, Fernández, Lopera Mármol, Navarro et al., Complejo Hospitalario Universitario de Ferrol
Baena-Díez, Grau, Forés, Fernández-Bergés, Elosua et al., en representación del estudio DARIOS. Prevalence of atrial fibrillation and its associated factors in Spain: An analysis of 6 population-based studies. DARIOS Study, Rev Clin Esp
Casas, Alejandre De O Ña, Beato, Alonso Gonzalo, Alonso Mu Ñoz et al., Hospital de Mataró
Casas-Rojo, Santos, Ñez-Cortés, Lumbreras-Bermejo, Ramos-Rincón et al., en nombre del Grupo SEMI-COVID-19 Network. Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry, Rev Clin Esp (Barc)
Charlson, Feinstein, A new clinical index of growth rate in the staging of breast cancer, Am J Med, doi:10.11909/j.issn.1671-5411.2019.01.005
De Llobregat, Barcelona) Xavier, Corbella, Formiga Pérez, Homs et al., Javier Tejada Montes Hospital Costa del Sol
Díez-Villanueva, Alfonso, Atrial fibrillation in the elderly, J Geriatr Cardiol, doi:10.11909/j.issn.1671-5411.2019.01.005
Ena, Enrique, Segado, Hospital General Defensa
Esther, Espartero, Rivas, De La Sierra Navas Alcántara, Tirado-Miranda ; Claudio et al., Complejo Asistencial Universitario de Salamanca (Salamanca) Gloria María Alonso
Gawałko, Kapłon-Cieślicka, Hohl, Dobrev, Linz, COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications, Int J Cardiol Heart Vasc
Gracia Gutiérrez, Esther, Trallero, Hospital U
Gómez, Pérez-Belmonte, Rubio-Rivas, None, Medicina Clínica
Gómez, Pérez-Belmonte, Rubio-Rivas, None, Medicina Clínica
Gómez, Pérez-Belmonte, Rubio-Rivas, None, Medicina Clínica
Gómez, Pérez-Belmonte, Rubio-Rivas, None, Medicina Clínica
Gómez-Doblas, Mu Ñiz, Martin, Rodríguez-Roca, Lobos et al., Prevalence of atrial fibrillation in Spain. OFRECE study results, Rev Esp Cardiol (Engl Ed)
Harrison, Fazio-Eynullayeva, Lane, Underhill, Lip, Atrial fibrillation and the risk of 30-day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID-19, J Arrhythm
José, Castro, Lorenzo López Reboiro, Sardi, González, Hospital Marina Baixa
Kohli, Meinert, Chong, Tesher, Fulminant myocarditis and atrial fibrillation in child with acute COVID-19, J Electrocardiol
Lawler, Goligher, Berger, Neal, Mcverry et al., TTACC Investigators. ACTIV-4a Investigators; REMAP-CAP Investigators. Therapeutic anticoagulation with heparin in noncritically ill patients with COVID-19, N Engl J Med
Mahoney, Barthel, Functional evaluation: The Barthel Index, Md State Med J
Manuel, Rojo, Manuel Ramos Rincón, Bermejo, Millán Nú Ñez-Cortés et al., Miembros del Grupo de SEMI-COVID-19
Musikantow, Turagam, Sartori, Chu, Kawamura et al., Atrial fibrillation in patients hospitalized with COVID-19: Incidence, predictors, outcomes, and comparison to influenza, JACC Clin Electrophysiol
Nadkarni, Bagiella, Chang, Moreno, Pujadas, Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19, J Am Coll Cardiol
Pardo Sanz, Tahoces, Pérez, Ferrer, Recalde et al., New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis, Cardiol J
Pérez-Villacastín, Castellano, Planas, Epidemiology of atrial fibrillation in Spain in the past 20 years, Rev Esp Cardiol (Engl Ed)
Ramos-Rincon, Buonaiuto, Ricci, Martín-Carmona, Paredes-Ruíz et al., SEMI-COVID-19 Network. Clinical characteristics and risk factors for mortality in very old patients hospitalized with COVID-19 in Spain, J Gerontol A Biol Sci Med Sci
Sattar, Connerney, Ullah, Philippou, Slack et al., COVID-19 presenting as takotsubo cardiomyopathy complicated with atrial fibrillation, Int J Cardiol Heart Vasc
Tomaszuk-Kazberuk, Kozi Ński, Domienik-Karłowicz, Jaguszewski, Darocha et al., Pharmacotherapy of atrial fibrillation in COVID-19 patients, Cardiol J
Uribarri, Nú Ñez-Gil, Aparisi, Arroyo-Espliguero, Eid et al., Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: An analysis of the international HOPE COVID-19 registry, Rev Esp Cardiol
Vanesa, Castro, María, Lomba, Aparicio et al., MEDCLI
Vasco, Santacruz, Valverde Mu, Ñoz, Hospital Comarcal de Blanes
Victoria Augustín Bandera, García Alegría, Jiménez-García, Luque Del Pino, Dolores Martín et al., None
Wallentin, Lindbäck, Eriksson, Hijazi, Eikelboom et al., Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation, Eur Heart J
Álvarez Díaz, López, Martul Pego, Pérez, Ferro et al., Hospital Infanta Margarita
{ 'indexed': {'date-parts': [[2022, 3, 10]], 'date-time': '2022-03-10T13:14:52Z', 'timestamp': 1646918092638}, 'reference-count': 22, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2022, 3, 1]], 'date-time': '2022-03-01T00:00:00Z', 'timestamp': 1646092800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'short-container-title': ['Medicina Clínica'], 'published-print': {'date-parts': [[2022, 3]]}, 'DOI': '10.1016/j.medcli.2022.01.008', 'type': 'journal-article', 'created': {'date-parts': [[2022, 3, 10]], 'date-time': '2022-03-10T12:47:26Z', 'timestamp': 1646916446000}, 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': [ 'Factores de riesgo de mortalidad en pacientes con infección por SARS-CoV-2 y fibrilación ' 'auricular: datos del registro SEMI-COVID-19'], 'prefix': '10.1016', 'author': [ {'given': 'Javier', 'family': 'Azaña Gómez', 'sequence': 'first', 'affiliation': []}, {'given': 'Luis M.', 'family': 'Pérez-Belmonte', 'sequence': 'additional', 'affiliation': []}, {'given': 'Manuel', 'family': 'Rubio-Rivas', 'sequence': 'additional', 'affiliation': []}, {'given': 'José', 'family': 'Bascuñana', 'sequence': 'additional', 'affiliation': []}, {'given': 'Raúl', 'family': 'Quirós-López', 'sequence': 'additional', 'affiliation': []}, { 'given': 'María Luisa', 'family': 'Taboada Martínez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Esther', 'family': 'Montero Hernandez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fernando', 'family': 'Roque-Rojas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Manuel', 'family': 'Méndez-Bailón', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ricardo', 'family': 'Gómez-Huelgas', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.medcli.2022.01.008_bib0115', 'unstructured': 'Word Health Organization. Novel coronavirus – China. 2020 [consultado 21 ' 'Sept 2021]. Disponible en: ' 'http://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0120', 'unstructured': 'Center for Systems Science and Engineering (CSSE) at Johns Hopkins ' 'University (JHU). COVID-19 Dashboard. 2020 [consultado 9 Ene 2022]. ' 'Disponible en: https://gisanddata.maps.arcgis. ' 'com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0125', 'doi-asserted-by': 'crossref', 'first-page': '28', 'DOI': '10.1093/gerona/glaa243', 'article-title': 'SEMI-COVID-19 Network. Clinical characteristics and risk factors for ' 'mortality in very old patients hospitalized with COVID-19 in Spain', 'volume': '76', 'author': 'Ramos-Rincon', 'year': '2021', 'journal-title': 'J Gerontol A Biol Sci Med Sci'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0130', 'first-page': '231', 'article-title': 'Atrial fibrillation and the risk of 30-day incident thromboembolic ' 'events, and mortality in adults ≥ 50 years with COVID-19', 'volume': '11', 'author': 'Harrison', 'year': '2020', 'journal-title': 'J Arrhythm.'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0135', 'doi-asserted-by': 'crossref', 'first-page': '4037', 'DOI': '10.1093/eurheartj/ehaa697', 'article-title': 'Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk ' 'factors for COVID-19 in two large cohorts of patients with atrial ' 'fibrillation', 'volume': '1', 'author': 'Wallentin', 'year': '2020', 'journal-title': 'Eur Heart J.'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0140', 'doi-asserted-by': 'crossref', 'first-page': '480', 'DOI': '10.1016/j.rce.2020.07.003', 'article-title': 'Clinical characteristics of patients hospitalized with COVID-19 in ' 'Spain: Results from the SEMI-COVID-19 Registry', 'volume': '220', 'author': 'Casas-Rojo', 'year': '2020', 'journal-title': 'Rev Clin Esp (Barc).'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0145', 'first-page': 'e12917', 'article-title': 'New-onset atrial fibrillation and multiple systemic emboli in a ' 'COVID-19 patient', 'volume': '13', 'author': 'Al-Abbas', 'year': '2021', 'journal-title': 'Cureus.'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0150', 'doi-asserted-by': 'crossref', 'article-title': 'Fulminant myocarditis and atrial fibrillation in child with acute ' 'COVID-19', 'author': 'Kohli', 'year': '2020', 'journal-title': 'J Electrocardiol.', 'DOI': '10.1016/j.jelectrocard.2020.10.004'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0155', 'doi-asserted-by': 'crossref', 'first-page': '34', 'DOI': '10.5603/CJ.a2020.0145', 'article-title': 'New-onset atrial fibrillation during COVID-19 infection predicts poor ' 'prognosis', 'volume': '28', 'author': 'Pardo Sanz', 'year': '2021', 'journal-title': 'Cardiol J.'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0160', 'first-page': '100631', 'article-title': 'COVID-19 associated atrial fibrillation: Incidence, putative mechanisms ' 'and potential clinical implications', 'volume': '30', 'author': 'Gawałko', 'year': '2020', 'journal-title': 'Int J Cardiol Heart Vasc.'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0165', 'first-page': '100580', 'article-title': 'COVID-19 presenting as takotsubo cardiomyopathy complicated with atrial ' 'fibrillation', 'volume': '29', 'author': 'Sattar', 'year': '2020', 'journal-title': 'Int J Cardiol Heart Vasc.'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0170', 'doi-asserted-by': 'crossref', 'first-page': '505', 'DOI': '10.1016/j.rce.2014.06.006', 'article-title': 'Prevalence of atrial fibrillation and its associated factors in Spain: ' 'An analysis of 6 population-based studies. DARIOS Study', 'volume': '214', 'author': 'Baena-Díez', 'year': '2014', 'journal-title': 'Rev Clin Esp.'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0175', 'doi-asserted-by': 'crossref', 'first-page': '561', 'DOI': '10.1016/j.recesp.2013.02.013', 'article-title': 'Epidemiology of atrial fibrillation in Spain in the past 20 years', 'volume': '66', 'author': 'Pérez-Villacastín', 'year': '2013', 'journal-title': 'Rev Esp Cardiol (Engl Ed).'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0180', 'doi-asserted-by': 'crossref', 'first-page': '259', 'DOI': '10.1016/j.recesp.2013.07.015', 'article-title': 'Prevalence of atrial fibrillation in Spain. OFRECE study results', 'volume': '67', 'author': 'Gómez-Doblas', 'year': '2014', 'journal-title': 'Rev Esp Cardiol (Engl Ed).'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0185', 'first-page': '49', 'article-title': 'Atrial fibrillation in the elderly', 'volume': '16', 'author': 'Díez-Villanueva', 'year': '2019', 'journal-title': 'J Geriatr Cardiol'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0190', 'doi-asserted-by': 'crossref', 'first-page': '527', 'DOI': '10.1016/0002-9343(80)90463-5', 'article-title': 'A new clinical index of growth rate in the staging of breast cancer', 'volume': '69', 'author': 'Charlson', 'year': '1980', 'journal-title': 'Am J Med.'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0195', 'first-page': '61', 'article-title': 'Functional evaluation: The Barthel Index', 'volume': '14', 'author': 'Mahoney', 'year': '1965', 'journal-title': 'Md State Med J.'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0200', 'article-title': 'Atrial fibrillation in patients with COVID-19. Usefulness of the ' 'CHA2DS2-VASc score: An analysis of the international HOPE COVID-19 ' 'registry', 'author': 'Uribarri', 'year': '2021', 'journal-title': 'Rev Esp Cardiol'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0205', 'doi-asserted-by': 'crossref', 'first-page': '1120', 'DOI': '10.1016/j.jacep.2021.02.009', 'article-title': 'Atrial fibrillation in patients hospitalized with COVID-19: Incidence, ' 'predictors, outcomes, and comparison to influenza', 'volume': '7', 'author': 'Musikantow', 'year': '2021', 'journal-title': 'JACC Clin Electrophysiol.'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0210', 'doi-asserted-by': 'crossref', 'first-page': '790', 'DOI': '10.1056/NEJMoa2105911', 'article-title': 'ACTIV-4a Investigators; REMAP-CAP Investigators. Therapeutic ' 'anticoagulation with heparin in noncritically ill patients with ' 'COVID-19', 'volume': '385', 'author': 'Lawler', 'year': '2021', 'journal-title': 'N Engl J Med.'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0215', 'doi-asserted-by': 'crossref', 'first-page': '1815', 'DOI': '10.1016/j.jacc.2020.08.041', 'article-title': 'Anticoagulation, bleeding, mortality, and pathology in hospitalized ' 'patients with COVID-19', 'volume': '76', 'author': 'Nadkarni', 'year': '2020', 'journal-title': 'J Am Coll Cardiol.'}, { 'key': '10.1016/j.medcli.2022.01.008_bib0220', 'doi-asserted-by': 'crossref', 'first-page': '758', 'DOI': '10.5603/CJ.a2021.0088', 'article-title': 'Pharmacotherapy of atrial fibrillation in COVID-19 patients', 'volume': '28', 'author': 'Tomaszuk-Kazberuk', 'year': '2021', 'journal-title': 'Cardiol J.'}], 'container-title': ['Medicina Clínica'], 'original-title': [], 'language': 'es', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0025775322000549?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0025775322000549?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2022, 3, 10]], 'date-time': '2022-03-10T12:47:43Z', 'timestamp': 1646916463000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0025775322000549'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 3]]}, 'references-count': 22, 'alternative-id': ['S0025775322000549'], 'URL': 'http://dx.doi.org/10.1016/j.medcli.2022.01.008', 'relation': {}, 'ISSN': ['0025-7753'], 'issn-type': [{'value': '0025-7753', 'type': 'print'}], 'subject': ['General Medicine'], 'published': {'date-parts': [[2022, 3]]}}
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit